Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Antioxidant activities of novel resveratrol analogs in breast cancer.

Chatterjee A, Ronghe A, Padhye SB, Spade DA, Bhat NK, Bhat HK.

J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.21925. Epub 2017 Sep 28.


A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.

Rebecca VW, Nicastri MC, McLaughlin N, Fennelly C, McAfee Q, Ronghe A, Nofal M, Lim CY, Witze E, Chude CI, Zhang G, Alicea GM, Piao S, Murugan S, Ojha R, Levi SM, Wei Z, Barber-Rotenberg JS, Murphy ME, Mills GB, Lu Y, Rabinowitz J, Marmorstein R, Liu Q, Liu S, Xu X, Herlyn M, Zoncu R, Brady DC, Speicher DW, Winkler JD, Amaravadi RK.

Cancer Discov. 2017 Nov;7(11):1266-1283. doi: 10.1158/2159-8290.CD-17-0741. Epub 2017 Sep 12.


Bilateral Anterior Opercular Syndrome.

Sequeira R, Kamble S, Bhore A, Ronghe A.

J Assoc Physicians India. 2017 Feb;65(2):85-86.


A rare case of lung cancer presenting as an ischioanal fossa mass.

Shetty N, Singh R, Naveed M, Ronghe AM, Barot FS.

Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):300-302. doi: 10.4103/0971-5851.195743.


4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.

Ronghe A, Chatterjee A, Singh B, Dandawate P, Abdalla F, Bhat NK, Padhye S, Bhat HK.

Toxicol Appl Pharmacol. 2016 Jun 15;301:1-13. doi: 10.1016/j.taap.2016.03.003. Epub 2016 Mar 9.


Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.

Ronghe A, Chatterjee A, Singh B, Dandawate P, Murphy L, Bhat NK, Padhye S, Bhat HK.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt B:500-12. doi: 10.1016/j.jsbmb.2014.09.015. Epub 2014 Sep 19.


Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesis.

Chatterjee A, Ronghe A, Singh B, Bhat NK, Chen J, Bhat HK.

J Biochem Mol Toxicol. 2014 Dec;28(12):529-38. doi: 10.1002/jbt.21594. Epub 2014 Aug 6.


Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.

Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK.

Carcinogenesis. 2014 Aug;35(8):1872-80. doi: 10.1093/carcin/bgu120. Epub 2014 Jun 3.


Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.

Singh B, Chatterjee A, Ronghe AM, Bhat NK, Bhat HK.

BMC Cancer. 2013 May 22;13:253. doi: 10.1186/1471-2407-13-253.


MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.

Singh B, Ronghe AM, Chatterjee A, Bhat NK, Bhat HK.

Carcinogenesis. 2013 May;34(5):1165-72. doi: 10.1093/carcin/bgt026. Epub 2013 Mar 14.


Novel Aza-resveratrol analogs: synthesis, characterization and anticancer activity against breast cancer cell lines.

Siddiqui A, Dandawate P, Rub R, Padhye S, Aphale S, Moghe A, Jagyasi A, Venkateswara Swamy K, Singh B, Chatterjee A, Ronghe A, Bhat HK.

Bioorg Med Chem Lett. 2013 Feb 1;23(3):635-40. doi: 10.1016/j.bmcl.2012.12.002. Epub 2012 Dec 11.


Supplemental Content

Loading ...
Support Center